Gastrointestinal transit times of a charcoal/sorbitol slurry in overdose patients

References

• Friedman E A, Feinstein E I, Beyer M M. Charcoal-induced lipid reduction in uremia. Kidney International 1978; 13: S170–176, (suppl 18)
   Google Scholar
• Cooney D. A superactive charcoal for antidotal use in poisonings. Clin Toxicol 1973; 11: 387–390
   Google Scholar
• Hayden J W, Comstock E G. Use of activated charcoal in acute poisoning. Clin Toxicol 1975; 8: 515–533
   PubMed Web of Science ®Google Scholar
• Levy G, Houston J B. Effect of activated charcoal on acetaminophen absorption. Pediatrics 1976; 58: 432
   PubMed Web of Science ®Google Scholar
• Levy G, Tsuchiya T. Effect of activated charcoal on aspirin absorption in man. Clin Pharmacol Ther 1972; 13: 317–322
   PubMed Web of Science ®Google Scholar
• Minocha A, Wiley S H, Chabbra D R. Superior efficacy of sorbitol cathartics in poisoned patients. Presented to AAPCC/AACT/ABMT/CAPCC Annual Scientific Meeting (Abstract 112), Santa Fe, NM, Sept, 251986
   Google Scholar
• Minocha A, Krenzelok E P, Spyker D A. Dosage recommendations for activated charcoal-sorbitol treatment. J Toxicol-Clin Toxicol 1985; 23: 579–587
   PubMedGoogle Scholar
• Neuvonen P J, Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine, and phenylbutazone in man. Eur J Clin Pharmacol 1980; 17: 51–57
   PubMed Web of Science ®Google Scholar
• Neuvonen P J, Olkkola K T. Effect of dose of charcoal on the absorption of diisopyramide, indomethacin, and trimethoprim by man. Eur J Clin Pharmacol 1984; 26: 761–767
   PubMed Web of Science ®Google Scholar
• Berg M J, Berlinger W G, Goldberg M J. Acceleration of the body clearance of phenobarbital by oral activated charcoal. N Engl J Med 1982; 307: 642–644
   PubMed Web of Science ®Google Scholar
• Ohning B L, Reed M D, Blumen J L. Continuous nasogastric administration of activated charcoal for the treatment of theophylline intoxication. Pediatr Pharmacol 1986; 5: 241–245
   PubMedGoogle Scholar
• Park G D, Spector R, Goldberg M J. Effect of the surface area of activated charcoal on theophylline clearance. J Clin Pharmacol 1984; 24: 289–292
   PubMed Web of Science ®Google Scholar
• Czajka P A, Konrad J D. Saline cathartics and the adsorptive capacity of activated charcoal for aspirin. Ann Emerg Med 1986; 15: 548–551
   PubMed Web of Science ®Google Scholar
• Curd-Sneed S D, McNatt L E, Stewart J J. Absorption of sodium pentobarbital by three types of activated charcoal. Vet Hum Toxicol 1986; 28: 524–526
   PubMedGoogle Scholar
• Cooney D O, Kane R P. “Superactive” charcoal adsorbs drugs as fast as standard antidotal charcoal. Clin Toxicol 1980; 16: 123–125
   PubMed Web of Science ®Google Scholar
• Ryan C F, Spigiel R W, Zeldes G. Enhanced adsorptive capacity of activated charcoal in the presence of magnesium citrate, NF. Clin Toxicol. 1980; 17: 456–461
   Google Scholar
• Krenzelok E P, Keller R, Stewart R D. Gastrointestinal transit times of cathartics combined with charcoal. Ann Emerg Med 1985; 14: 1152–1155
   PubMed Web of Science ®Google Scholar
• Lambert R J, Kindler B J, Schaeffer D J. The efficacy of superactivated charcoal in treating rats exposed to a lethal oral dose of potassium cyanide. Ann Emerg Med 1988; 17: 595–598
   PubMed Web of Science ®Google Scholar
• Garten V A, Weiss D E. Ion and electron exchange properties of activated carbon in relation to its behavior as a catalyst and adsorbent. Rev Pure Appl Chem 1957; 7: 69
   Google Scholar
• Decker W J, Combs H F, Corby D G. Adsorption of drugs and poisons by activated charcoal. Toxicol Appl Pharmacol 1968; 13: 454–460
   PubMed Web of Science ®Google Scholar
• Anderson A H. Experimental studies on the pharmacology of activated charcoal, I. Adsorption power of charcoal in aqueous solutions. Acta Pharmacologica 1946; 2: 69–78
   Google Scholar
• Hulten B A, Heath A, Mellstrand T. Does alcohol absorb to activated charcoal. Human Toxicol 1985; 5: 211–212
   Google Scholar
• Minocha A, Herold D A, Barth J T. Activated charcoal in oral ethanol absorption-lack of effect in humans. J Toxicol-Clin Toxicol 1986; 24: 225–234
   PubMed Web of Science ®Google Scholar
• Corby D G, Decker W J. Management of acute poisoning with activated charcoal. Pediatrics 1974; 54: 324–328
   PubMed Web of Science ®Google Scholar
• Pollack M M, Dunbar B S, Holbrook P R. Aspiration of activated charcoal and gastric contents. Ann Emerg Med 1981; 10: 528–529
   PubMed Web of Science ®Google Scholar
• Justiniani F R, Hippalgaonka R, Martinez L O. Charcoal-containing empyema complicating treatment for overdose. Chest 1985; 87: 404–405
   PubMed Web of Science ®Google Scholar
• Pond S M. Role of repeated oral doses of activated charcoal in clinical toxicology. Med Toxicol 1986; 1: 3–11
   PubMedGoogle Scholar
• Neuvonen P J. Clinical pharmakokinetics of oral activated charcoal in acute intoxications. Clin Pharmacokinet 1982; 7: 465–489
   PubMed Web of Science ®Google Scholar
• Holt L E, Holz P H. The black bottle. J Pediatr 1968; 63: 306–314
   Google Scholar
• Curd-Sneed C D, Parks K S, Bordelon J G. In vitro adsorption of sodium pentobarbital by Superchar, USP, and Darco G-60 activated charcoals. J Toxicol-Clin Toxicol 1987; 25: 1–11
   PubMed Web of Science ®Google Scholar
• Filippone G A, Fish S S, Lacouture P G. Reversible adsorption (desorption) of aspirin from activated charcoal. Arch Intern Med 1987; 147: 1390–1392
   PubMed Web of Science ®Google Scholar
• Riegel J M, Becker C E. Use of cathartics in toxic ingestions. Ann Emerg Med 1981; 10: 254–258
   PubMed Web of Science ®Google Scholar
• Krenzelok E P. Gastrointestinal transit times of cathartics used with activated charcoal. Clin Pharm 1985; 4: 446–448
   PubMedGoogle Scholar
• Picchioni A L, Chin L, Gillespie T. Evaluation of activated charcoalsorbitol suspension as an antidote. J Toxicol-Clin Toxicol 1982; 19: 433–444
   PubMed Web of Science ®Google Scholar
• Kulig K, Bar-Or D, Cantrill S V. Management of acutely poisoned patients without gastric emptying. Ann Emerg Med 1985; 14: 562–567
   PubMed Web of Science ®Google Scholar
• Dockstrader L L, Lawrence R A, Bresnick H L. Home administration of activated charcoal-feasibility and acceptance. Presented to AAPCC/AACT/ABMT/CAPCC Annual Scientific Meeting (Abstract #1), Sante Fe, NM, September, 251986
   Google Scholar